Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland
BACKGROUND AND AIMS A previous analysis of hepatitis C virus (HCV)-related healthcare costs in Switzerland found that the annual healthcare costs of untreated HCV infection (excluding antiviral treatment) could increase by more than 25 million Swiss francs (CHF) between 2013 and 2030. Si...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2019-03-01
|
| Rangatū: | Swiss Medical Weekly |
| Ngā marau: | |
| Urunga tuihono: | https://www.smw.ch/index.php/smw/article/view/2598 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|